Researchers find genetic fingerprints to predict efficacy of immunotherapy
Israeli researchers have identified a genetic "fingerprint" that helps predict the effectiveness of immunotherapy treatments, according to a study.
The study, by the Israel Institute of Technology (Technion), stated that the discovery would help improve the personalisation of immunotherapy treatments, Xinhua news agency reported.
Immunotherapy is considered to be one of the greatest revolutions in cancer treatment. It enhances the immune system's ability to target and destroy cancer cells efficiently.
However, a major challenge in immunotherapy is the unpredictability of patient responses. Some patients do not benefit and may experience side effects without significant improvement.
Therefore, there is a need to identify biomarkers that can forecast the effectiveness of treatment based on the specific data of each patient.
In their study, published in the journal Cell Genomics, the team examined the genetic characteristics of T-cell clones -- groups of multiplied immune T cells that specialise in targeting a specific threat once recognised -- and their influence on treatment success.
To achieve the goal, the team conducted a large-scale meta-analysis using single-cell RNA sequencing and T-cell receptor sequencing data from cancer patients undergoing immunotherapy.
It was found that although these T-cell clones are present in both responsive and non-responsive patients, those who respond to immunotherapy display a distinct genetic signature in their T-cell clones, and the treatment boosts their immune activity.
Another major finding was that in non-responsive patients, some T-cell clones were simultaneously found both in the bloodstream and the tumour.
To achieve a better immune response, it is crucial to activating T-cell clones located solely within the tumour, rather than those present in both the tumour and the bloodstream, the researchers said.
They added that this discovery will enhance predictive capabilities and could lead to new treatment strategies that improve the effectiveness of immunotherapy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
Israeli gunfire kills 17 people near Gaza aid site, health officials say
Israeli gunfire killed at least 17 Palestinians and wounded dozens as thousands of displaced people approached an aid distribution site of a U.S.-backed humanitarian group in central Gaza on Tuesday, local health authorities said. Medics said the casualties were rushed at two hospitals, the Al-Awda Hospital in Nuseirat camp in central Gaza, and the Al-Quds in Gaza City, in the north. The Israeli military said they are looking into the incident. Last week it warned Palestinians not to approach routes leading to sites of the U.S.-backed Gaza Humanitarian Foundation (GHF) between 6 p.m. and 6 a.m. local time, describing these roads as closed military zones. There was no immediate GHF comment on Tuesday's incident. The GHF began distributing food packages in Gaza at the end of May, overseeing a new model of aid distribution which the United Nations says is neither impartial nor neutral. Live Events Many Gazans say they have to walk for hours to reach the sites, meaning they have to start travelling well before dawn if they are to stand any chance of receiving food. While the GHF has said there have been no incidents at its so-called secure distribution sites, Palestinians seeking aid have described disorder, and access routes to the sites have been beset by chaos and deadly violence. "I went there at 2 a.m. hoping to get some food, on my way there, I saw people returning empty-handed, they said aid packages have run out in five minutes, this is insane and isn't enough," said Mohammad Abu Amr, 40, a father of two. "Dozens of thousands arrive from the central areas and from the northern areas too, some of them walked for over 20 km (12 miles), only to come back home with disappointment," he told Reuters via a chat app. He said he heard the firing but did not see what happened. Later on Tuesday, local health authorities said an Israeli strike on a house in Deir al-Balah in central Gaza Strip killed eight people, taking Tuesday's death toll to at least 25. The Israeli military said separately, it intercepted one rocket fired from northern Gaza towards Israeli territories, which signalled Hamas and other militant group remained able to fire the weapons despite Israeli devastation of their arsenal. Israel allowed limited U.N.-led operations to resume on May 19 after an 11-week blockade in the enclave of 2.3 million people, where experts have warned a famine looms. The U.N. has described the aid allowed into Gaza as "drop in the ocean." Witnesses said at least 40 trucks carrying flour for U.N. warehouses were looted by desperate displaced Palestinians as well as thieves near Nabulsi roundabout along the coastal road in Gaza City. The war erupted after Hamas-led militants took 251 hostages and killed 1,200 people, most of them civilians, in the Oct. 7, 2023, attack, Israel's single deadliest day. Israel's military campaign has since killed more than 54,000 Palestinians, most of them civilians, according to health authorities in Gaza, and flattened much of the coastal enclave.
NDTV
12 hours ago
- NDTV
Gaza's Al-Amal Hospital "Virtually Out Of Service": WHO
Gaza City: The Al-Amal Hospital in Gaza, one of the few still operating in the Palestinian territory, is now "virtually out of service" due to intense military activity, the head of the WHO said Monday. "Access to the hospital is obstructed, preventing new patients from reaching care, and leading to more preventable deaths," the World Health Organization's director-general Tedros Adhanom Ghebreyesus posted on X. Tedros said two emergency medical teams - one local, the other international - "are still doing their best to serve the remaining patients with the limited medical supplies left on the premises." "With the closure of Al-Amal, Nasser Medical Complex is now the only remaining hospital with an intensive care unit in Khan Younis," he said. The WHO said June 5 that al-Nasser and Al-Amal hospitals were unable to fully treat the wounded that continue to pour in because of serious shortages of medicines and medical supplies after two months of total blockade. Israeli authorities have recently allowed in some humanitarian aid, but way less than what is needed. Nearly 20 months of relentless war, triggered by Hamas' October 7, 2023 attacks on Israel, has created one of the most serious humanitarian crises in the world, with civilians exhausted by bombardments, forced displacement and hunger.
Hans India
a day ago
- Hans India
Vietnam's capital reports 150 new Covid-19 cases in past week
Hanoi: Vietnamese capital Hanoi confirmed 150 new Covid-19 cases in the city from May 30 to June 6, slightly down from the previous week, reports said. Since the beginning of 2025, the capital city has recorded 558 infections, a decrease of 109 cases compared to the same period last year, the report said. The Hanoi Centre for Disease Control has requested local units to strengthen public communication on Covid-19 and other seasonal diseases, Xinhua news agency reported, citing the Vietnam News Agency. Meanwhile, Covid cases are once again on the rise in India, with 5,364 active cases currently reported and four deaths recorded in the last 24 hours. Since January 1, more than 4,700 people in India have recovered from the virus, while 55 fatalities have been reported during this period. The primary driver of the recent surge is a new coronavirus variant known as NB.1.8.1, a subvariant of Omicron. This strain has been detected in several countries, including the United Kingdom, the United States, Australia, Thailand, China, and Hong Kong. NB.1.8.1 was first identified in January 2025 and is classified as a "recombinant" variant—meaning it emerged through the genetic mixing of two or more previous strains. On May 23, 2025, the World Health Organisation (WHO) designated NB.1.8.1 as a "Variant Under Monitoring" (VUM). According to the WHO's 2023 definition, a VUM is a variant that has undergone genetic changes that may affect the virus's characteristics. Early data suggests that NB.1.8.1 may spread more easily or grow faster than other variants, though this has yet to be confirmed. The impact of NB.1.8.1 on health, immunity, and transmission is still being studied. However, lab-based models indicate that the strain binds more efficiently to human cell receptors, suggesting it may infect cells more effectively than earlier variants. Common symptoms associated with NB.1.8.1 include sore throat, cough, fever, muscle aches, and nasal congestion. Some patients also report gastrointestinal symptoms such as nausea and diarrhoea. Despite the emergence of this new strain, health experts emphasise that vaccines continue to offer strong protection against infection, severe illness, hospitalisation, and death.
